Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.8560
-0.0166 (-1.90%)
May 2, 2025, 4:00 PM EDT - Market closed
RVPH Employees
Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$2,137,057
Market Cap
40.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RVPH News
- 5 weeks ago - Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress - GlobeNewsWire
- 3 months ago - Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Reviva to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewsWire
- 4 months ago - Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit - GlobeNewsWire
- 4 months ago - Reviva Announces Proposed Public Offering - GlobeNewsWire
- 5 months ago - Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low - Seeking Alpha
- 6 months ago - Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 months ago - Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024 - GlobeNewsWire